Diagnostics & Research
The Diagnostics & Research industry has a total of 48 stocks, with a combined market cap of $621.68 billion, total revenue of $169.13 billion and a weighted average PE ratio of 35.20.
Market Cap
621.68B
Revenue
169.13B
Profits
17.66B
PE Ratio
35.20
Profit Margin
10.44%
Dividend Yield
0.27%
48 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 165.75B | -2.89% | 2,801,577 | 45.20B |
| 2 | DHR | Danaher Corporation | 117.48B | -0.16% | 6,527,021 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 41.70B | -0.98% | 600,867 | 4.45B |
| 4 | WAT | Waters Corporation | 32.89B | -4.91% | 1,233,783 | 3.77B |
| 5 | A | Agilent Technologies, Inc. | 31.86B | -0.14% | 2,328,913 | 7.07B |
| 6 | IQV | IQVIA Holdings Inc. | 28.77B | -1.53% | 1,516,047 | 16.63B |
| 7 | NTRA | Natera, Inc. | 27.97B | -4.35% | 1,664,305 | 2.50B |
| 8 | ILMN | Illumina, Inc. | 21.94B | -0.48% | 2,089,027 | 4.39B |
| 9 | DGX | Quest Diagnostics Incorporated | 21.13B | 0.35% | 693,146 | 11.28B |
| 10 | LH | Labcorp Holdings Inc. | 20.86B | -1.14% | 475,785 | 14.14B |
| 11 | MTD | Mettler-Toledo International Inc. | 20.72B | -4.38% | 344,771 | 4.09B |
| 12 | GH | Guardant Health, Inc. | 13.06B | -1.47% | 1,640,344 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.10B | 0.96% | 473,997 | 2.68B |
| 14 | RVTY | Revvity, Inc. | 10.60B | -4.32% | 1,136,018 | 2.90B |
| 15 | ICLR | ICON Public Limited Company | 8.96B | -3.74% | 641,129 | 8.10B |
| 16 | CRL | Charles River Laboratories International, Inc. | 7.84B | -3.46% | 734,994 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 6.76B | -2.97% | 4,032,489 | 2.10B |
| 18 | SHC | Sotera Health Company | 4.41B | -0.96% | 11,760,886 | 1.19B |
| 19 | BLLN | BillionToOne, Inc. | 4.17B | -3.86% | 613,565 | 354.54M |
| 20 | RDNT | RadNet, Inc. | 4.17B | -5.39% | 1,066,208 | 2.14B |
| 21 | TWST | Twist Bioscience Corporation | 3.39B | -2.79% | 984,982 | 409.48M |
| 22 | VCYT | Veracyte, Inc. | 3.05B | -3.31% | 1,107,419 | 541.74M |
| 23 | GRAL | GRAIL, Inc. | 2.60B | -2.44% | 502,740 | 156.12M |
| 24 | ADPT | Adaptive Biotechnologies Corporation | 2.10B | -3.67% | 1,285,899 | 295.41M |
| 25 | WGS | GeneDx Holdings Corp. | 1.16B | -1.39% | 1,154,137 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.08B | -5.60% | 1,467,218 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.06B | -3.69% | 449,739 | 412.82M |
| 28 | OPK | OPKO Health, Inc. | 838.15M | 0.91% | 1,729,829 | 581.12M |
| 29 | PSNL | Personalis, Inc. | 669.17M | 5.79% | 5,780,489 | 64.52M |
| 30 | CSTL | Castle Biosciences, Inc. | 550.49M | -2.58% | 664,497 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 453.27M | 1.01% | 435,845 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 352.29M | -8.35% | 1,989,912 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 295.68M | -2.33% | 152,598 | 92.39M |
| 34 | BNR | Burning Rock Biotech Limited | 176.76M | -0.42% | 2,957 | 77.14M |
| 35 | IMDX | Insight Molecular Diagnostics Inc. | 164.67M | 2.41% | 288,465 | 4.06M |
| 36 | BDSX | Biodesix, Inc. | 147.97M | -7.05% | 53,592 | 96.10M |
| 37 | FONR | FONAR Corporation | 123.64M | - | 32,888 | 105.34M |
| 38 | MDXH | MDxHealth SA | 100.16M | 4.28% | 2,192,480 | 107.88M |
| 39 | XGN | Exagen Inc. | 83.77M | -6.47% | 297,614 | 68.38M |
| 40 | PRPO | Precipio, Inc. | 51.22M | 0.07% | 50,416 | 24.05M |
| 41 | QUCY | Quantum Cyber N.V. | 16.77M | 315.12% | 535,334,093 | 537.08K |
| 42 | MBAI | Check-Cap Ltd. | 14.58M | 18.34% | 1,178,430 | - |
| 43 | NOTV | Inotiv, Inc. | 10.80M | 27.18% | 3,772,042 | 507.36M |
| 44 | XWEL | XWELL, Inc. | 10.78M | -2.16% | 80,038 | 29.21M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 8.49M | 0.53% | 150,150 | 5.66M |
| 46 | ISPC | iSpecimen Inc. | 7.60M | -7.27% | 189,280 | 1.93M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 7.02M | -2.58% | 36,031 | - |
| 48 | ADVB | Advanced Biomed Inc. | 6.48M | -9.18% | 28,978 | - |